Echocardiogram: References

Echocardiogram. American Heart Association. http://www.heart.org/HEARTORG/Conditions/HeartAttack/SymptomsDiagnosisofHeartAttack/Echocardiogram---Echo_UCM_451485_Article.jsp#.V4-f9k0m6ZM. Updated September 3, 2015. Accessed July 2016.

Transesophageal echocardiography (TEE). American Heart Association. http://www.heart.org/HEARTORG/Conditions/HeartAttack/SymptomsDiagnosisofHeartAttack/Transesophageal-Echocardiography-TEE_UCM_441655_Article.jsp#.V4-gz00m6ZM. Updated September 11, 2015. Accessed July 2016.

Zamorano JL, Badono LP, Bruce C, et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular disease. European Journal of Echocardiograph DOI: http://dx.doi.org/10.1093/ejechocard/jer086 557-584 First published online: 12 August 2011. http://ehjcimaging.oxfordjournals.org/content/12/8/557. Accessed July 2016.

Pediatric echocardiography. Children’s National Health System. http://childrensnational.org/choose-childrens/conditions-and-treatments/heart/echocardiography. Accessed July 2016.

Cohen JL, Cheirif J, Segar DS, et al. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial. J Am Coll Cardiol 1998; 32:746.

Kitzman DW, Goldman ME, Gillam LD, et al. Efficacy and safety of the novel ultrasound contrast agent perflutren (definity) in patients with suboptimal baseline left ventricular echocardiographic images. Am J Cardiol 2000; 86:669.

Boolani H, Main M. Update on contrast echocardiography: Safety and Utility. Curr Cardiovasc Imaging Rep 2012; 5:410.